Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
0.906
+0.012 (1.33%)
At close: Nov 22, 2024, 4:00 PM
0.890
-0.015 (-1.71%)
After-hours: Nov 22, 2024, 7:54 PM EST

Tempest Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-35.52-29.49-35.71-28.3-19.21-14.37
Depreciation & Amortization
0.430.380.640.370.340.1
Stock-Based Compensation
5.072.551.561.110.450.31
Other Operating Activities
1.681.881.571.480.47-8.3
Change in Accounts Payable
0.56-0.260-0.21-0.570.95
Change in Other Net Operating Assets
-1.27-2.410.87-0.4-0.5-0.26
Operating Cash Flow
-29.05-27.36-31.07-25.96-19.02-21.56
Capital Expenditures
-0.44-0.17-0.56-0.14-0.05-1.36
Other Investing Activities
---0.040.04-
Investing Cash Flow
-0.44-0.17-0.56-0.1-0.01-1.36
Long-Term Debt Issued
---15--
Long-Term Debt Repaid
---4.74---
Net Debt Issued (Repaid)
-2.2--4.7415--
Issuance of Common Stock
43.135.68.8633.530.070.04
Other Financing Activities
--7.2810.53-0.47-0.04
Financing Cash Flow
40.935.611.459.0634.623
Net Cash Flow
11.418.08-20.2333.0115.580.08
Free Cash Flow
-29.49-27.53-31.63-26.09-19.07-22.92
Free Cash Flow Per Share
-1.31-1.79-2.74-6.88-40.73-27.34
Cash Interest Paid
1.251.251.540.95--
Cash Income Tax Paid
0.190.190.02--0
Levered Free Cash Flow
-20.43-17.47-18.33-16.38-12.89-
Unlevered Free Cash Flow
-19.52-16.57-17.32-15.58-12.89-
Change in Net Working Capital
-0.211.1-2.690.061.57-
Source: S&P Capital IQ. Standard template. Financial Sources.